The antibiotic Raxar was approved in November 1997 despite evidence from clinical studies suggesting it could cause several fatal heart-rhythm disruptions. Click on FAQ on Arrhythmia: Raxar, to learn more about this issue.
When Raxar clinical trials came under review by the FDA, a medical officer suspected that two out of four patients who died after taking Raxar in clinical trials possibly suffered heart-rhythm disturbances caused by the drug. FDA officials, however, chose...MORE >>
Links and Resources
Featured Articles on Raxar
- June 06, 2003 - Glaxo compensates Otsuka for abandoning antibiotic
- August 15, 2001 - Undue Influence: How the drug industry's power goes unchecked and why the problem is likely to get worse
- January 15, 2001 - Beware These Drugs: They're linked to sudden death
- December 20, 2000 - Drug After Drug: Raxar warning ignored
- March 1, 2000 - Overexposed
- November 1, 1999 - Withdrawal of Product: Raxar
Browse Books About Drug Litigation 1.The Drug Lords : America's... 2.Deadly Drug Interactions : The People's... 3.The Pdr Family Guide to Prescription... 4.The Essential Guide to Prescription... 5.2001 Mosby's GenRx: A Comprehensive... 6.The American Pharmaceutical...